Jones Financial Companies Lllp Acquires 5,408 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH)

Jones Financial Companies Lllp increased its stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 1,827.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,704 shares of the company’s stock after purchasing an additional 5,408 shares during the quarter. Jones Financial Companies Lllp owned 0.09% of VanEck Pharmaceutical ETF worth $492,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the company. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management raised its position in shares of VanEck Pharmaceutical ETF by 117.4% during the 4th quarter. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management now owns 200,000 shares of the company’s stock valued at $17,256,000 after purchasing an additional 108,000 shares during the period. Adamsbrown Wealth Consultants LLC grew its holdings in shares of VanEck Pharmaceutical ETF by 102.3% in the fourth quarter. Adamsbrown Wealth Consultants LLC now owns 149,631 shares of the company’s stock worth $12,910,000 after purchasing an additional 75,659 shares during the last quarter. Thrivent Financial for Lutherans grew its stake in VanEck Pharmaceutical ETF by 33.6% in the third quarter. Thrivent Financial for Lutherans now owns 234,890 shares of the company’s stock worth $22,322,000 after purchasing an additional 59,025 shares in the last quarter. Blue Chip Partners LLC bought a new stake in shares of VanEck Pharmaceutical ETF in the fourth quarter valued at about $2,139,000. Finally, Miller Investment Management LP increased its holdings in VanEck Pharmaceutical ETF by 13.4% during the third quarter. Miller Investment Management LP now owns 207,535 shares of the company’s stock valued at $19,722,000 after buying an additional 24,446 shares during the period.

VanEck Pharmaceutical ETF Price Performance

PPH opened at $93.69 on Tuesday. VanEck Pharmaceutical ETF has a 1 year low of $84.48 and a 1 year high of $99.51. The business’s 50-day moving average is $88.99 and its two-hundred day moving average is $91.33. The firm has a market capitalization of $584.63 million, a PE ratio of 30.55 and a beta of 0.72.

VanEck Pharmaceutical ETF Increases Dividend

The firm also recently announced a dividend, which was paid on Monday, December 30th. Investors of record on Friday, December 27th were paid a dividend of $0.411 per share. This is an increase from VanEck Pharmaceutical ETF’s previous dividend of $0.36. The ex-dividend date of this dividend was Friday, December 27th.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.